These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9474473)

  • 1. Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals.
    Jelliffe RW; Schumitzky A; Bayard D; Milman M; Van Guilder M; Wang X; Jiang F; Barbaut X; Maire P
    Clin Pharmacokinet; 1998 Jan; 34(1):57-77. PubMed ID: 9474473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goal-oriented, model-based drug regimens: setting individualized goals for each patient.
    Jelliffe R
    Ther Drug Monit; 2000 Jun; 22(3):325-9. PubMed ID: 10850402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
    Bondareva IB; Jelliffe RW; Sokolov AV; Tischenkova IF
    J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens.
    Jelliffe R; Bayard D; Milman M; Van Guilder M; Schumitzky A
    Ther Drug Monit; 2000 Jun; 22(3):346-53. PubMed ID: 10850404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?
    Tod MM; Padoin C; Petitjean O
    Clin Pharmacokinet; 2001; 40(11):803-14. PubMed ID: 11735603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive control of drug dosage regimens: basic foundations, relevant issues, and clinical examples.
    Jelliffe RW; Maire P; Sattler F; Gomis P; Tahani B
    Int J Biomed Comput; 1994 Jun; 36(1-2):1-23. PubMed ID: 7927847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations.
    Thomson AH; Staatz CE; Tobin CM; Gall M; Lovering AM
    J Antimicrob Chemother; 2009 May; 63(5):1050-7. PubMed ID: 19299472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some comments and suggestions concerning population pharmacokinetic modeling, especially of digoxin, and its relation to clinical therapy.
    Jelliffe RW
    Ther Drug Monit; 2012 Aug; 34(4):368-77. PubMed ID: 22735674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control.
    Jelliffe RW; Schumitzky A; Van Guilder M; Liu M; Hu L; Maire P; Gomis P; Barbaut X; Tahani B
    Ther Drug Monit; 1993 Oct; 15(5):380-93. PubMed ID: 8249044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin therapeutics and monitoring: a contemporary approach.
    Avent ML; Vaska VL; Rogers BA; Cheng AC; van Hal SJ; Holmes NE; Howden BP; Paterson DL
    Intern Med J; 2013 Feb; 43(2):110-9. PubMed ID: 23185970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaco-informatics: more precise drug therapy from 'multiple model' (MM) adaptive control regimens: evaluation with simulated vancomycin therapy.
    Jelliffe RW; Bayard D; Schumitzky A; Milman M; Van Guilder M
    Medinfo; 1995; 8 Pt 2():1106-10. PubMed ID: 8591381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring in neonates.
    Pauwels S; Allegaert K
    Arch Dis Child; 2016 Apr; 101(4):377-81. PubMed ID: 26803050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic optimisation of vancomycin therapy.
    Leader WG; Chandler MH; Castiglia M
    Clin Pharmacokinet; 1995 Apr; 28(4):327-42. PubMed ID: 7648760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
    Stockmann C; Sherwin CM; Zobell JT; Lubsch L; Young DC; Olson J; Noyes BE; Ampofo K; Spigarelli MG
    Pharmacotherapy; 2013 Dec; 33(12):1288-96. PubMed ID: 23824677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer.
    Jodrell DI; Reyno LM; Sridhara R; Eisenberger MA; Tkaczuk KH; Zuhowski EG; Sinibaldi VJ; Novak MJ; Egorin MJ
    J Clin Oncol; 1994 Jan; 12(1):166-75. PubMed ID: 8270974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.
    Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H
    J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
    Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M
    J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a novel approach for dose individualization in pharmacotherapy using gabapentin in a proof of principles study.
    Blau GE; Orcun S; Laínez JM; Reklaitis GV; Suvannasankha A; Fausel C; Anaissie EJ
    Pharmacotherapy; 2013 Jul; 33(7):727-35. PubMed ID: 23553679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.